Auckland-based human and animal immunodiagnostics firm Pictor has once again tapped one of its better-known shareholders to lead a new investment round that it hopes will place it squarely under the nose of some of America’s largest investment firms.
Former Morrison & Co CEO Marko Bogoievski, who
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
